Insufficient scRNA-seq data for expression of DXO at single-cell level.
Insufficient scRNA-seq data for expression of DXO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1165.86 | 1445 / 1445 | 100% | 12.44 | 183 / 183 |
liver | 100% | 1865.26 | 226 / 226 | 100% | 17.47 | 406 / 406 |
ovary | 100% | 2457.76 | 180 / 180 | 100% | 27.65 | 430 / 430 |
pancreas | 100% | 936.67 | 328 / 328 | 100% | 15.14 | 178 / 178 |
stomach | 100% | 1129.50 | 359 / 359 | 100% | 14.19 | 286 / 286 |
thymus | 100% | 2089.58 | 653 / 653 | 100% | 20.96 | 605 / 605 |
uterus | 100% | 1886.15 | 170 / 170 | 100% | 21.07 | 459 / 459 |
prostate | 100% | 2089.69 | 245 / 245 | 100% | 24.48 | 501 / 502 |
skin | 100% | 912.61 | 1808 / 1809 | 100% | 20.79 | 471 / 472 |
intestine | 100% | 1298.10 | 966 / 966 | 100% | 15.64 | 525 / 527 |
brain | 100% | 1231.50 | 2630 / 2642 | 100% | 25.10 | 705 / 705 |
breast | 100% | 1408.13 | 459 / 459 | 99% | 17.38 | 1110 / 1118 |
lung | 100% | 1251.57 | 578 / 578 | 99% | 14.70 | 1144 / 1155 |
bladder | 100% | 1373.62 | 21 / 21 | 99% | 17.22 | 498 / 504 |
adrenal gland | 100% | 3146.87 | 258 / 258 | 99% | 25.43 | 227 / 230 |
kidney | 100% | 1620.24 | 89 / 89 | 99% | 14.51 | 889 / 901 |
adipose | 100% | 1186.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 17.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.07 | 29 / 29 |
spleen | 100% | 1990.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.87 | 1 / 1 |
blood vessel | 100% | 1274.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 846.72 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 449.42 | 747 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 569.77 | 810 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071028 | Biological process | nuclear mRNA surveillance |
GO_0090304 | Biological process | nucleic acid metabolic process |
GO_0110155 | Biological process | NAD-cap decapping |
GO_0000956 | Biological process | nuclear-transcribed mRNA catabolic process |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0050779 | Biological process | RNA destabilization |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0008409 | Molecular function | 5'-3' exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0110152 | Molecular function | RNA NAD+-cap (NAD+-forming) hydrolase activity |
GO_0034353 | Molecular function | mRNA 5'-diphosphatase activity |
GO_0000166 | Molecular function | nucleotide binding |
Gene name | DXO |
Protein name | Decapping nuclease (EC 3.6.1.-) Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-) |
Synonyms | DOM3Z DOM3L NG6 |
Description | FUNCTION: Decapping enzyme for NAD-capped RNAs: specifically hydrolyzes the nicotinamide adenine dinucleotide (NAD) cap from a subset of RNAs by removing the entire NAD moiety from the 5'-end of an NAD-capped RNA . The NAD-cap is present at the 5'-end of some RNAs and snoRNAs . In contrast to the canonical 5'-end N7 methylguanosine (m7G) cap, the NAD cap promotes mRNA decay . Preferentially acts on NAD-capped transcripts in response to environmental stress . Also acts as a non-canonical decapping enzyme that removes the entire cap structure of m7G capped or incompletely capped RNAs and mediates their subsequent degradation (By similarity). Specifically degrades pre-mRNAs with a defective 5'-end m7G cap and is part of a pre-mRNA capping quality control (By similarity). Has decapping activity toward incomplete 5'-end m7G cap mRNAs such as unmethylated 5'-end-capped RNA (cap0), while it has no activity toward 2'-O-ribose methylated m7G cap (cap1) . In contrast to canonical decapping enzymes DCP2 and NUDT16, which cleave the cap within the triphosphate linkage, the decapping activity releases the entire cap structure GpppN and a 5'-end monophosphate RNA (By similarity). Also has 5'-3' exoribonuclease activities: The 5'-end monophosphate RNA is then degraded by the 5'-3' exoribonuclease activity, enabling this enzyme to decap and degrade incompletely capped mRNAs . Also possesses RNA 5'-pyrophosphohydrolase activity by hydrolyzing the 5'-end triphosphate to release pyrophosphates (By similarity). Exhibits decapping activity towards FAD-capped RNAs . Exhibits decapping activity towards dpCoA-capped RNAs in vitro (By similarity). . FUNCTION: Decapping enzyme for NAD-capped RNAs: specifically hydrolyzes the nicotinamide adenine dinucleotide (NAD) cap from a subset of RNAs by removing the entire NAD moiety from the 5'-end of an NAD-capped RNA. . FUNCTION: Decapping enzyme for NAD-capped RNAs: specifically hydrolyzes the nicotinamide adenine dinucleotide (NAD) cap from a subset of RNAs by removing the entire NAD moiety from the 5'-end of an NAD-capped RNA. . |
Accessions | O77932 ENST00000480240.5 ENST00000432110.5 ENST00000426498.5 F8WC68 ENST00000446967.5 ENST00000427627.1 ENST00000375349.7 ENST00000419797.6 ENST00000443250.5 ENST00000439989.5 ENST00000454430.2 ENST00000375356.7 ENST00000427690.5 ENST00000458308.5 ENST00000495340.5 H7C5D2 ENST00000337523.10 ENST00000383330.4 ENST00000399937.5 ENST00000399936.5 ENST00000414092.2 ENST00000453742.2 |